Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment

© 2015 The Author 2015. Background. The approved tenofovir disoproxil fumarate (TDF) dose of 300 mg every 48 hours for adults with moderate renal impairment is often confusing and inconvenient. Using a new TDF formulation, we compared the pharmacokinetics of the standard dose with a dose of 150 mg o...

Saved in:

書目詳細資料
Main Authors:	Tim R. Cressey, Anchalee Avihingsanon, Guttiga Halue, Prattana Leenasirimakul, Pra Ornsuda Sukrakanchana, Yardpiroon Tawon, Nirattiya Jaisieng, Gonzague Jourdain, Anthony T. Podany, Courtney V. Fletcher, Virat Klinbuayaem, Chureeratana Bowonwatanuwong
格式:	雜誌
出版:	2018
主題:	Agricultural and Biological Sciences
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84938634555&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44904
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
由: Tim R. Cressey, et al.
出版: (2018)

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
由: Tim R. Cressey, et al.
出版: (2020)

Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors
由: Geoffroy Liegeon, et al.
出版: (2019)

Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
由: David V. Glidden, et al.
出版: (2018)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Temofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Temofovir Disoproxil Fumarate Monotherapy
由: Vera E. Bukkems, et al.
出版: (2020)

Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, noninferiority trial
由: Pedro Cahn, et al.
出版: (2019)

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
由: Pedro Cahn, et al.
出版: (2018)

Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review
由: Marieke Bierhoff, et al.
出版: (2020)

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
由: Tim R. Cressey, et al.
出版: (2018)

Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)
由: Paul K. Drain, et al.
出版: (2020)

Pharmacokinetics of Atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate
由: Torsak Bunupuradah, et al.
出版: (2018)

Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate
由: Phuphuakrat A.
出版: (2023)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
由: Marc M. Solomon, et al.
出版: (2018)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
由: Tavitiya Sudjaritruk, et al.
出版: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
由: Marc M. Solomon, et al.
出版: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
由: Solomon M.M., et al.
出版: (2014)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
由: Tavitiya Sudjaritruk, et al.
出版: (2018)

Tenofovir Disoproxil Fumarate (TDF) Prenatal Sebagai Pelengkap Tatalaksana Pencegahan Transmisi Vertikal Virus Hepatitis B
由: Avianita Dewi Kusumawardhani
出版: (2020)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
由: Linda Aurpibul, et al.
出版: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
由: Linda Aurpibul, et al.
出版: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
由: Linda Aurpibul, et al.
出版: (2018)

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
由: Avihingsanon A.
出版: (2023)

Effectiveness and safety of rosuvastatin 10 mg once daily versus every other day in outpatients with hypercholesterolemia
由: Chutiporn Kitiyadisai
出版: (2004)

Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency
由: Supawadee Suppadungsuk, et al.
出版: (2022)

Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency
由: Suppadungsuk S.
出版: (2023)

Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review
由: Bagus Setyoboedi, Bagus, et al.

Comparison of viral control between two tenofovir dose reduction regimens (300 mg every 48 hours versus 300 mg every 72 hours) in chronic hepatitis B patients with moderate renal impairment from tenofovir-induced renal dysfunction
由: Watcharasak Chotiyaputta, et al.
出版: (2020)

Incidence rate and time to occurrence of renal impairment and chronic kidney disease among thai hiv-infected adults with tenofovir disoproxil fumarate use
由: Jirayu Visuthranukul, et al.
出版: (2022)

Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis
由: Marieke Bierhoff, et al.
出版: (2022)

Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
由: Gonzague Jourdain, et al.
出版: (2018)

Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavir
由: Tim R. Cressey, et al.
出版: (2018)

Vitamin D and Calcium Supplement Attenuate Bone Loss among HIVInfected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial
由: Patawee Boontanondha, et al.
出版: (2020)

Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living with HIV: Week 24 Results from IMPAACT 2014
由: Melvin A.J.
出版: (2023)

Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
由: Jourdain G., et al.
出版: (2017)

Characterization of high performance Mg/MgO nanocomposites
由: Goh, C.S., et al.
出版: (2014)

Mg-based composite reinforced by Mg2Si
由: Lu, L., et al.
出版: (2014)

Evaluation of Mg compounds as coating materials in Mg batteries
由: Chen, T, et al.
出版: (2020)

Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus
由: Nicolas Salvadori, et al.
出版: (2019)

Erratum : Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight band dosing(Pediatr Infect Dis J. (2015)34(392-397))
由: Kulkanya Chokephaibulkit
出版: (2018)

Formation of nanocrystalline Mg2Si and Mg2Si dispersion strengthened Mg-Al alloy by mechanical alloying
由: Lu, L., et al.
出版: (2014)